Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity

Fig. 7

Analysis of open field test NPs treatment prior (0–30 min) and post (30–60 min) amphetamine IP uptake using ANOVA. Recorded tracking of amphetamine-induced hyperactivity screening model during 60 min session of distance travelled (a), time mobile (b) and center time (c). Occupancy heat maps and plots produced by the ANY-maze software (d1-2–i1-2)

Back to article page